Skip to main content
SpringerLink
Log in

In-vitro-Aktivität und Resistenz bei 4-Chinolonen

  • Übersicht
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H. A new class of chemotherapeutic agents. J. Med. Pharm. Chem. 5 (1962) 1063–1065.

    Google Scholar 

  2. Bauernfeind, A.: Teichomycin and AM-715 activity on staphylococci and enterococci in comparison to other antibiotic Agents. 21st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago 1981, Abstract 428.

  3. Van der Waaij, D. Colonization resistance of the digestive tract: clinical consequences and implications. J. Antimicrob. Chemother. 10 (1982) 263–270.

    Google Scholar 

  4. Saito, A., Sawatari, K., Fukuda, Y., Nagasawa, M., Koga, H., Tomonaga, A., Nakazato, H., Fujita, K., Shigeno, Y., Suzuyama, Y., Yamaguchi, K., Izumikawa, K., Hara, K. Susceptibility ofLegionella pneumophila to ofloxacinin vitro and in experimental Legionella Pneumonia in guinea pigs. Antimicrob. Agents Chemother. 28 (1985) 15–20.

    Google Scholar 

  5. Gay, J. D., De Young, D. R., Roberts, G. D. In vitro activities of norfloxacin and ciprofloxacin againstMycobacterium tuberculosis, M. avium complex,M. chelonei, M. fortuitum andM. kansasii. Antimicrob. Agents Chemother. 26 (1984) 94–96.

    Google Scholar 

  6. Gaya, H., Chadwick, M. V. In vitro of ciprofloxacin against mycobacteria. Eur. J. Clin. Microbiol. 4 (1985) 345–347.

    Google Scholar 

  7. Valero-Guillen, P. L., Martin-Luengo, F., Quintanilla, I. Mycobacterium fortuitum. J. Antimicrob. Chemother. 15 (1985) 254–255.

    Google Scholar 

  8. Bauernfeind, A., Petermüller, C., Danninger, J.: Reduction of sensitivity to pefloxacin (PEF), ofloxacin (OFL), norfloxacin (NOR) and ciprofloxacin (CIP) inPs. aeruginosa (ps. ae.). Program and Abstract of the 24th ICAAC 1984, A 460.

  9. Bauernfeind, A., Petermüller, C.: Progress in chemotherapeutic heterocyclic carbonic acids. Drugs under Experimental and Clincial Research IX (1983) 545–553.

  10. Barry, A. L., Jones, R. N. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid afterin vitro selection of resistant populations. Antimicrob. Agents Chemother. 25 (1984) 775–777.

    Google Scholar 

  11. Sauerwein, D., Bauernfeind, A. Klinische Erfahrungen bei Behandlung von Harnwegsinfekten bei Querschnittgelähmten mit Norfloxacin. FAC 3–5 (1984) 759–764.

    Google Scholar 

  12. Sauerwein, D., Bauernfeind, A., Petermüller, C.: Clinical and bacteriological evaluation of ciprofloxacin (CIP) in treatment of UTIs of para-and tetraplegic patients. 14th International Congress of Chemotherapy, Kyoto 1985, p-12-41.

  13. Steckmeier, B., Thetter, D., Welter, H. W., Schmölder, A., Siebeck, M., Bauernfeind, A.: Clinical, microbiological and pharmacokinetic aspects of ciprofloxacin in therapy of wound infections after vascular surgery. Prod. 14th International Congress of Chemotherapy, Tokyo 1985, 1697–1698.

Download references

Author information

Authors and Affiliations

  1. Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Pettenkoferstraße 9a, D-8000, Müchen 2

    A. Bauernfeind

Authors
  1. A. Bauernfeind
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauernfeind, A. In-vitro-Aktivität und Resistenz bei 4-Chinolonen. Infection 14 (Suppl 3), S186–S187 (1986). https://doi.org/10.1007/BF01667840

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01667840

Search

Navigation